UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D. C. 20549

FORM 10QSB

(X) Quarterly report pursuant to Section 13 or 15(d) of the Securities

Exchange Act of 1934 for the quarterly period ended March 31, 2001

( ) Transition report pursuant of Section 13 or 15(d) of the Securities
Exchange Act of 1939 for the transition period ____ to______

COMMISSION FILE NUMBER: 333-50914
--------

SPICOLOGY, INC.
------------------------------------------
(Exact name of registrant as specified in its charter)

California 91-2021595
- ---------------------------------- ----------------------------
(State or other jurisdiction of (IRS Employer I.D. Number)
incorporation or organization)

809 Ocean Avenue
Seal Beach, California 90740
(562) 596-6646
- -------------------------------------------------------------------------------
(Address of Principal Executive Offices, including Registrant's zip code
and telephone number)

NONE
--------------------------------------------------------------
Former name, former address and former fiscal year, if changed

Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports,), and (2) has been subject to
such filing requirements for the past 90 days. Yes X No
--- ---

The number of shares of the registrant's common stock as of March 31, 2001:
2,030,900 shares.

Transitional Small Business Disclosure Format (check one): Yes No X
--- ---
1

TABLE OF CONTENTS
-----------------

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements

(a) Balance Sheet
(b) Statement of Operations
(c) Statement of Changes in Financial Position
(d) Statement of Shareholders' Equity
(e) Notes to Financial Statements

Item 2. Management's Discussion and Analysis
of Financial Condition and Results of Operations

Item 3. Risks

PART II. OTHER INFORMATION

Item 1. Legal Proceedings

Item 2. Changes in Securities and Use of Proceeds

Item 3. Defaults On Senior Securities

Item 4. Submission of Items to a Vote

Item 5. Other Information

Item 6
(a) Exhibits
(b) Reports on Form 8K

SIGNATURES

FINANCIAL DATA SCHEDULE

SPICOLOGY, INC.
(A DEVELOPMENT STAGE COMPANY)
BALANCE SHEETS

March 31, 2001 December 31, 2000
-------------- -----------------
Assets: ............................................ $ -- $ --
======= =======
Liabilities - Accounts Payable ..................... $ -- $ --
-------
Stockholders' Equity:
common stock, Par value $.001

Authorized 100,000,000 shares,
Issued 2,000,000 shares at December 31, 2000 2,000 2,000
Paid-In Capital .................................. 2,000 2,000
Retained Deficit (4,000) (4,000)
------ -------
Total Stockholders' Equity .................... -- --
------- -------
Total Liabilities and
Stockholders' Equity ........................ $ -- $ --
======= =======

The accompanying notes are an integral part of these financial statements.

SPICOLOGY, INC.
(A DEVELOPMENT STAGE COMPANY)
STATEMENT OF OPERATION

December 31, 2000 March 31, 2001
----------------- --------------
Revenues: .................................. $ -- $ --

Expenses:
General and Administrative Expenses: .... $ 4,000 $ 4,000
------ ------

Net Loss .............................. $ (4,000) $ (4,000)
====== ======
Loss per share (basic and diluted).......... $ (.002) $ (.002)
====== ======

Weighted average common shares outstanding 2,000,000 2,000,000

The accompanying notes are an integral part of these financial statements.

F-3

SPICOLOGY, INC.
(A DEVELOPMENT STAGE COMPANY)
STATEMENT OF STOCKHOLDERS' EQUITY
FOR THE PERIOD MARCH 21, 2000
THROUGH MARCH 31, 2001

Common stock Additional
Number of Shares Amount Paid in Retained
Capital (Deficit) Total
----------------- -------- --------- --------- -----
Stocks issued for cash $2,000 $2,000
Stocks issued for services 2,000,000 $2,000 $2,000

Net loss for the period $(2,000) $(2,000)
12/31/2000
Balance at 3/31/2001 2,000,000 $2,000 $2,000 $(4,000) $ 0
----------------- -------- --------- --------- -----

The accompanying notes are an integral part of these financial statements.

SPICOLOGY, INC.
(A DEVELOPMENT STAGE COMPANY)
STATEMENTS OF CASH FLOWS
For the period March 21, 2000 (inception)
through December 31, 2000

CASH FLOWS FROM OPERATING
ACTIVITIES:
Operating Activities
Net Loss ............................................ $(4,000) $ -0-
------- -------
Adjustments to reconcile net loss to
net cash used in operating activities
Stocks issued for services at fair value 2,000 $ -0-
------- -------
Net Cash Used by operating activities ......... ... (2,000) $ -0-
------- -------
Financing activities
Stockholder contribution 2,000 $ -0-
------- -------
Net Cash Provided by
Financing Activities .............................. 2,000 $ -0-
------- -------
Net increase (decrease) in cash and cash equivalents -- --
Cash and Cash Equivalents
Beginning of Year.. ............................ -- --
Cash and Cash Equivalents
End of Year ................................. $ -- --
======= =======
Non cash activities:
Stocks issued for services as fair value $ 2,000 $ -0-

The accompanying notes are an integral part of these financial statements.

SPICOLOGY, INC.
(A Development Stage Company)
Notes to Financial Statements
March 31, 2001

NOTE 1 NATURE OF BUSINESS

Spicology, Inc. was incorporated under the laws of the State of California on
March 21, 2000. It is engaged in the business of selling culinary spices from
its e-commerce equipped web site, which is now in development. Spicology has
been in the development stage since its formation. Planned principal operations
have commenced recently but have not generated any revenue.

NOTE 2 SIGNIFICANT ACCOUNTING POLICIES

Basis - Spicology uses the accrual method of accounting.
Cash and cash equivalents - Spicology considers all short term, highly liquid
investments that are readily convertible within three months to known amounts
as cash equivalents. Currently, it has no cash equivalents. Primary earnings
per share amounts are based on the weighted average number of shares
outstanding at the dates of the financial statements. Fully diluted earnings
per share shall be shown on stock options and other convertible issues that may
be exercised within ten years of the financial statement dates.

Estimates The preparation of the financial statements in conformity with
generally accepted accounting principles requires management to make estimates
and assumptions that affect the amounts reported in the financial statement and
accompanying notes. Actual results could differ from those estimates.

NOTE 3 INCOME TAXES

Spicology has adopted the provisions of SFAS No. 109 "Accounting for Income
Taxes". SFAS 109 requires recognition of deferred tax liabilities and assets
for the expected future tax consequences of events that have been included in
the financial statements or tax returns. Under this method, deferred tax
liabilities and assets are determined based on the differences between the
financial statement and tax basis of assets and liabilities using enacted tax
rates in effect for the year in which the differences are expected to reverse.
Spicology, Inc. has incurred losses that can be carried forward to offset
future earnings if conditions of the Internal Revenue Codes are met.

NOTE 4 RELATED PARTY TRANSACTIONS

Spicology issued 1,800,000 shares of unregistered common stock to its sole
officer in exchange for his services. These were recorded in the books at par
value ($.001).

Spicology shares office space and telephone services of its president at no
charge, and it pays no officer salaries at the present time.

It also shares office space and telephone services of the President of
Spicology at no charge. General and administrative expenses were also paid to
officers who are also stockholders of Spicology.

NOTE 5 GOING CONCERN
Spicology has nominal assets and no current operations with which to create
operating capital. It seeks to raise operating capital through private
placements of its common stock. However, it is unknown if such offering or
negotiations will be successful.

-----------------------------------------------------------------
-----------------------------------------------------------------

PART I. FINANCIAL INFORMATION

Item 2. Management's Discussion and Analysis of Financial Condition and
Results of Operations.

THIS ANALYSIS CONTAINS FORWARD-LOOKING COMMENTS WHICH ARE BASED ON CURRENT
INFORMATION. ACTUAL RESULTS IN THE FUTURE MAY DIFFER MATERIALLY.

The Company is engaged in the business of establishing a web site for spice
sales. The Company has just commenced operations, and a comparative analysis of
financial information is not relevant.

PART II.

Item 1. Legal proceedings NONE

Item 2. Changes in securities and use of proceeds NONE

Item 3. Defaults on senior securities NONE

Item 4. Submission of items to a vote NONE

Item 5. Other information NONE

Item 6.

a) Exhibits NONE
b) Reports on 8K NONE

SIGNATURES

In accordance with the requirements of the Securities and Exchange Act of 1934,
the registrant caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.

SPICOLOGY.COM

Dated: April 27, 2001 By: Rick Feinstein
---------------------
Rick Feinstein, President

Dated: April 27, 201 By: Rick Feinstein
------------------------------
Rick Feinstein
Chief Financial Officer